28473083|t|ACR Appropriateness Criteria (Â®) Radiologic Management of Mesenteric Ischemia
28473083|a|Mesenteric vascular insufficiency is a serious medical condition that may lead to bowel infarction, morbidity, and mortality that may approach 50%. Recommended therapy for acute mesenteric ischemia includes aspiration embolectomy, transcatheter thrombolysis, and angioplasty with or without stenting for the treatment of underlying arterial stenosis. Nonocclusive mesenteric ischemia may respond to transarterial infusion of vasodilators such as nitroglycerin, papaverine, glucagon, and prostaglandin E1. Recommended therapy for chronic mesenteric ischemia includes angioplasty with or without stent placement and, if an endovascular approach is not possible, surgical bypass or endarterectomy. The diagnosis of median arcuate ligament syndrome is controversial, but surgical release may be appropriate depending on the clinical situation. Venous mesenteric ischemia may respond to systemic anticoagulation alone. Transhepatic or transjugular superior mesenteric vein catheterization and thrombolytic infusion can be offered depending on the severity of symptoms, condition of the patient, and response to systemic anticoagulation. Adjunct transjugular intrahepatic portosystemic shunt creation can be considered for outflow improvement. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND / UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
28473083	0	3	ACR	T092	UMLS:C1515941
28473083	44	54	Management	T058	UMLS:C0376636
28473083	58	77	Mesenteric Ischemia	T038	UMLS:C1412000
28473083	78	111	Mesenteric vascular insufficiency	T038	UMLS:C1412000
28473083	160	176	bowel infarction	T038	UMLS:C0241950
28473083	212	220	approach	T082	UMLS:C0449445
28473083	238	245	therapy	T058	UMLS:C0087111
28473083	250	275	acute mesenteric ischemia	T038	UMLS:C0001363
28473083	285	295	aspiration	T058	UMLS:C0349707
28473083	296	307	embolectomy	T058	UMLS:C0162575
28473083	309	322	transcatheter	T058	UMLS:C0203005
28473083	323	335	thrombolysis	T058	UMLS:C0040044
28473083	341	352	angioplasty	T058	UMLS:C0162577
28473083	369	377	stenting	T058	UMLS:C2348535
28473083	386	395	treatment	T058	UMLS:C0087111
28473083	410	427	arterial stenosis	T017	UMLS:C0238397
28473083	429	461	Nonocclusive mesenteric ischemia	T038	UMLS:C3852986
28473083	477	499	transarterial infusion	T058	UMLS:C0021439
28473083	503	515	vasodilators	T103	UMLS:C0042402
28473083	524	537	nitroglycerin	T103	UMLS:C0017887
28473083	539	549	papaverine	T103	UMLS:C0030350
28473083	551	559	glucagon	T103	UMLS:C0017687
28473083	565	581	prostaglandin E1	T103	UMLS:C0002335
28473083	595	602	therapy	T058	UMLS:C0087111
28473083	607	634	chronic mesenteric ischemia	T038	UMLS:C0311262
28473083	644	655	angioplasty	T058	UMLS:C0162577
28473083	672	687	stent placement	T058	UMLS:C0522776
28473083	699	720	endovascular approach	T058	UMLS:C1997114
28473083	738	753	surgical bypass	T058	UMLS:C1536078
28473083	757	771	endarterectomy	T058	UMLS:C0014098
28473083	777	786	diagnosis	T033	UMLS:C0011900
28473083	790	822	median arcuate ligament syndrome	T038	UMLS:C1861783
28473083	845	853	surgical	T058	UMLS:C0543467
28473083	918	924	Venous	T082	UMLS:C0348013
28473083	925	944	mesenteric ischemia	T038	UMLS:C1412000
28473083	969	984	anticoagulation	T058	UMLS:C0003281
28473083	992	1004	Transhepatic	T082	UMLS:C0589464
28473083	1021	1045	superior mesenteric vein	T017	UMLS:C0226742
28473083	1132	1140	symptoms	T033	UMLS:C1457887
28473083	1142	1166	condition of the patient	T033	UMLS:C0683521
28473083	1193	1208	anticoagulation	T058	UMLS:C0003281
28473083	1218	1272	transjugular intrahepatic portosystemic shunt creation	T058	UMLS:C0339897
28473083	1320	1349	American College of Radiology	T092	UMLS:C1515941
28473083	1394	1404	guidelines	T170	UMLS:C0162791
28473083	1418	1437	clinical conditions	T033	UMLS:C0683521
28473083	1470	1500	multidisciplinary expert panel	T097	UMLS:C1319406
28473083	1506	1515	guideline	T170	UMLS:C0162791
28473083	1552	1570	extensive analysis	T062	UMLS:C0936012
28473083	1606	1628	peer-reviewed journals	T170	UMLS:C2985503
28473083	1669	1682	methodologies	T062	UMLS:C0086912
28473083	1684	1688	RAND	T170	UMLS:C3826892
28473083	1723	1789	Grading of Recommendations Assessment, Development, and Evaluation	T170	UMLS:C0282574
28473083	1793	1798	GRADE	T170	UMLS:C0282574
28473083	1831	1838	imaging	T058	UMLS:C0079595
28473083	1843	1863	treatment procedures	T058	UMLS:C0087111
28473083	2022	2029	imaging	T058	UMLS:C0079595
28473083	2033	2042	treatment	T058	UMLS:C0087111